OCT, photoacoustics, and ultrasound combo detects ovarian cancer earlier

Combining three previously unrelated imaging tools—optical coherence tomography (OCT), photoacoustic imaging, and ultrasound—into one new device, a team of researchers from the University of Connecticut (Storrs, CT) and the University of Southern California (Los Angeles, CA) have found a new approach to diagnosing early-stage ovarian cancer in high-risk women through minimally invasive surgery. The new technique may be better than the current standard procedure of preemptively removing the ovaries.

Described by the team in the September issue of Biomedical Optics Express, the diagnostic device combines the contrast provided by photoacoustic imaging, the high-resolution subsurface imaging provided by OCT, and the deeper tissue imaging provided by pulse-echo ultrasound. They tested their device by imaging both pig and human ovarian tissue, and correctly identified malignant tumors that were later confirmed by staining the tissue and examining it under a microscope. These initial tests were performed on tissue that had been surgically removed, but the device's 5 mm diameter is small enough that it could potentially be inserted through a small slit to image tissue in live patients.

Co-registered images of malignant ovarian tissue obtained with the hybrid imaging device: OCT image (top), ultrasound image (middle),  superimposed photoacoustic and ultrasound image (second middle), and corresponding histology (bottom). Yellow diamond arrow: malignant tissue. (Image courtesy of University of Connecticut/Biomedical Optics Express)


Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Follow OptoIQ on your iPhone; download the free app here.

Subscribe now to BioOptics World magazine; it's free!

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

(SLIDESHOW) View the July/August 2013 issue

ONCOLOGY/CANCER TREATMENT: Study reveals potential of terahertz pulses to fight cancer

Terahertz (THz) photons don't have sufficient energy to break apart the bonds that bind DNA in a cell's nucleus.

OPTOACOUSTICS/OXIMETRY: Real-time photoacoustics beats pulse oximetry by measuring oxygenation in single cells

Red blood cells ferry oxygen to a body's cells and tissues by way of arteries, veins, and capillaries.

SPECTROSCOPY/ONCOLOGY/GYNECOLOGY: First-ever minimally invasive ovarian cancer screen is spectroscopy-based

Researchers at Northwestern University and NorthShore University HealthSystem have previously demonstrated the ability of partial-wave spectroscopy to detect subtle changes in cells that indicate c...


Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...



Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS